{
  "id": 18904391,
  "title": "STAT+: Why the latest heart drug failures should make us all more skeptical of AI hype",
  "url": "https://urgent.news/2026/11/08/stat-why-the-latest-heart-drug-failures-should-make-us-all-more",
  "topic": "ai",
  "section": "AI",
  "published": "2026-11-08T09:30:00.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/2026/11/08/heart-drug-failures-lessons-for-artificial-intelligence-from-aha-conference/"
  },
  "original_language": "en",
  "account": "In recent years, the promise of artificial intelligence (AI) and other new technologies to revolutionize healthcare has come under scrutiny. Two recent studies presented at the American Heart Association meeting serve as a stark reminder of the challenges faced by pharmaceutical researchers. Despite advancements in genetic understanding, a Novartis drug called pelacarsen failed to reduce the incidence of heart attacks and strokes, despite being expected to lower the blood substance lp(a). Additionally, a Novo Nordisk study on an anti-inflammatory targeting the protein IL-6 also found no benefit. These failures should serve as a cautionary tale, urging us to approach claims of AI-driven healthcare breakthroughs with a healthy dose of skepticism.",
  "summary": "Once again, a hot new technology that was supposed to speed up drug research has fallen flat.",
  "key_points": [
    "Novartis drug pelacarsen failed to reduce heart attack/stroke incidence",
    "Anti-inflammatory targeting IL-6 protein found no benefit in Novo Nordisk study",
    "AI-driven healthcare breakthroughs require healthy skepticism"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}